Literature DB >> 33596350

Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine.

Xiang Wang1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 33596350     DOI： 10.1056/NEJMc2036242

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  12 in total

Review 1.  Comprehensive narrative review of real-world COVID-19 vaccines: viewpoints and opportunities.

Authors:  Shelan Liu; Min Kang; Na Zhao; Yali Zhuang; Shijian Li; Tie Song
Journal:  Med Rev (Berl)       Date:  2022-05-25

Review 2.  COVID-19 Vaccines in Older Adults: Challenges in Vaccine Development and Policy Making.

Authors:  Chih-Kuang Liang; Wei-Ju Lee; Li-Ning Peng; Lin-Chieh Meng; Fei-Yuan Hsiao; Liang-Kung Chen
Journal:  Clin Geriatr Med       Date:  2022-03-21       Impact factor: 3.529

3.  Clinical and Radiological Follow-Up of a Pfizer-BioNTech COVID-19 Vaccine-Induced Hemichorea-Hemiballismus.

Authors:  Cédric Batot; Maryane Chea; Sinead Zeidan; Marie Mongin; Gabriel Pop; Julie Mazoyer; Bertrand Degos
Journal:  Tremor Other Hyperkinet Mov (N Y)       Date:  2022-05-18

4.  Acute Hepatitis of Unknown Origin (AHUO)-The Puzzle Ahead.

Authors:  Consolato M Sergi
Journal:  Diagnostics (Basel)       Date:  2022-05-12

5.  Determining the Cutoff Points of the 5C Scale for Assessment of COVID-19 Vaccines Psychological Antecedents among the Arab Population: A Multinational Study.

Authors:  Ramy Mohamed Ghazy; Samar Abd ElHafeez; Ramy Shaaban; Iffat Elbarazi; Marwa Shawky Abdou; Ahmed Ramadan; Khalid A Kheirallah
Journal:  J Prim Care Community Health       Date:  2021 Jan-Dec

6.  Single-cell profiling of T and B cell repertoires following SARS-CoV-2 mRNA vaccine.

Authors:  Suhas Sureshchandra; Sloan A Lewis; Brianna M Doratt; Allen Jankeel; Izabela Coimbra Ibraim; Ilhem Messaoudi
Journal:  JCI Insight       Date:  2021-12-22

Review 7.  Pharmacological Treatment of Secondary Lymphedema.

Authors:  Stav Brown; Joseph H Dayan; Michelle Coriddi; Adana Campbell; Kevin Kuonqui; Jinyeon Shin; Hyeung Ju Park; Babak J Mehrara; Raghu P Kataru
Journal:  Front Pharmacol       Date:  2022-01-25       Impact factor: 5.810

8.  Modeling COVID-19 dynamic using a two-strain model with vaccination.

Authors:  Ugo Avila-Ponce de León; Eric Avila-Vales; Kuan-Lin Huang
Journal:  Chaos Solitons Fractals       Date:  2022-02-16       Impact factor: 9.922

9.  A siRNA targets and inhibits a broad range of SARS-CoV-2 infections including Delta variant.

Authors:  Yi-Chung Chang; Chi-Fan Yang; Yi-Fen Chen; Chia-Chun Yang; Yuan-Lin Chou; Hung-Wen Chou; Tein-Yao Chang; Tai-Ling Chao; Shu-Chen Hsu; Si-Man Ieong; Ya-Min Tsai; Ping-Cheng Liu; Yuan-Fan Chin; Jun-Tung Fang; Han-Chieh Kao; Hsuan-Ying Lu; Jia-Yu Chang; Ren-Shiuan Weng; Qian-Wen Tu; Fang-Yu Chang; Kuo-Yen Huang; Tong-Young Lee; Sui-Yuan Chang; Pan-Chyr Yang
Journal:  EMBO Mol Med       Date:  2022-02-21       Impact factor: 12.137

10.  Modeling the Transmission of the SARS-CoV-2 Delta Variant in a Partially Vaccinated Population.

Authors:  Ugo Avila-Ponce de León; Eric Avila-Vales; Kuanlin Huang
Journal:  Viruses       Date:  2022-01-16       Impact factor: 5.048
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.